Covid - 19: Laboratoire Cerba Detects First Case of Omicron Variant in Mainland France

December 3, 2021

Laboratoire Cerba, a global leader in specialized clinical pathology and member of the Cerba HealthCare Group, has detected a case of the Omicron......

Asian stocks close lower on Omicron virus variant worries

November 30, 2021

Asian stocks ended weak on Monday as worries about the detection of the Omicron coronavirus variant continued to weigh on sentiment. Some of the......

Zia Chishti Resigns from All Roles at TRG and its Affiliates Effective Immediately

November 29, 2021

The Boards of Directors of TRG Pakistan Ltd. (TRGP) and The Resource Group International Limited (TRGI) announce that Zia Chishti has resigned from......

Masimo Rad-G® Helps Clinicians Identify Pediatric Pneumonia in Large Field Trial in India

November 29, 2021

- Masimo (NASDAQ: MASI) today announced the findings of a study published in Clinical Medicine Insights: Pediatrics in which Dr. Harish Kumar and......

​​​​​​​​​​​​​​Galderma to Acquire Award-winning ALASTIN Skincare® Enhancing Its Integrated Dermatology Platform to Continue Delivering the Best Experience to Patients

November 29, 2021

Galderma, the world’s largest independent dermatology company, announced that it has signed a definitive agreement to acquire ALASTIN Skincare®,......

The Role of Walnuts in Healthy Aging

November 28, 2021

Research on the role of diet and healthy aging continues to evolve. Limited evidence suggests that dietary patterns containing vegetables, fruits,......

Vifor Pharma supports Iron Deficiency Day 2021: Call to action for early iron deficiency diagnosis

November 26, 2021

• Iron Deficiency Day unites a strong international coalition dedicated to...
  Continue Reading >

Major Advances in Diagnosing Cancers Associated With the Human Papillomavirus

November 25, 2021

- The Institut de Cancérologie de Lorraine [the Lorraine Institute of Oncology, or ICL] in collaboration with the Institut du Cancer Joliot......

How Cosmetic Gynaecology is Re-Shaping Women’s Intimate Life

November 25, 2021

For women of all ages, access to proper and timely intimate health care services is vital to maintaining a sound quality of life. Physical and emotional......

Takeda’s LIVTENCITYTM (maribavir) Approved by U.S. FDA as the First and Only Treatment for People Ages 12 and Older with Post-Transplant Cytomegalovirus (CMV), Refractory (With or Without Genotypic Resistance) to Conventional Antiviral Therapies

November 24, 2021

- In the Phase 3 SOLSTICE study, more than twice the proportion of adult transplant recipients with refractory or resistant (R/R) CMV infection/disease......